$0.97
+0.01 (+1.50%)
Open$0.96
Previous Close$0.96
Day High$1.02
Day Low$0.94
52W High$3.28
52W Low$1.09
Volume—
Avg Volume1.28M
Market Cap569.09M
P/E Ratio—
EPS$-1.84
SectorPharmaceuticals
Analyst Ratings
Strong Sell
13 analysts
Price Target
+2,315.0% upside
Current
$0.97
$0.97
Target
$23.50
$23.50
$17.63
$23.50 avg
$33.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.41B | 1.74B | 156.52M |
| Net Income | -3,133,446,944 | -3,491,089,687 | 22.40M |
| Profit Margin | -222.4% | -211.2% | 14.3% |
| EBITDA | -567,458,671 | -667,350,504 | 28.04M |
| Free Cash Flow | — | — | 15.05M |
| Rev Growth | -19.2% | -19.2% | +1.7% |
| Debt/Equity | 0.67 | 0.67 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |